Patients with advanced cancer often experience symptoms related to increasing tumor burden, cancer treatments, and psychosocial stressors. They also have significant social, informational, and decision-making needs. Palliative care practitioners have developed expertise to address many of these supportive care concerns through interprofessional teamwork, validated assessments, multidimensional interventions, and frequent communication. In this article, we aim to provide an evidence-based update on several important palliative care topics, including management of pain, fatigue, anorexia-cachexia, depression, and anxiety, as well as patient-clinician communication and decision-making. Multiple randomized controlled trials have demonstrated that palliative care can improve symptom burden, quality of life, quality of care, satisfaction, and possibly survival and cost of care. To enhance the level of care for patients with advanced cancer, oncologists need to have a good working knowledge of the major palliative care principles, and to refer patients to palliative care programs often and early in the disease trajectory.
Comprehensive Cancer Network (NCCN), 10 the Institute of Medicine (IOM) 3 , and the American College of Surgeons Commission on Cancer (CoC) 11 have promoted an increase in the availability and integration of palliative care programs in cancer centers. we shall provide an evidence-based review on some of the main palliative care skills, summarize the clinical outcomes related to palliative care programs, and discuss contemporary models to integrate palliative care with oncology.
Palliative Care Skills Physical Symptoms
Common symptoms in patients with advanced cancer include fatigue, pain, dyspnea, nausea and vomiting, anorexia, weight loss, and delirium. 12 Figure   3 illustrates the complex interaction among various symptoms, and how symptom expression can be modulated by multiple factors. For instance, pain expression may be exacerbated by psychologic distress. Understanding of this symptom expression cascade has multiple implications. First, symptoms occur commonly and often together, making it essential to assess them with symptom batteries. Second, symptoms are usually multifactorial in nature, necessitating multidimensional interventions. Third, symptoms can often be anticipated and should thus be screened routinely and managed expectantly. The remainder of this section focuses on several common symptoms, namely fatigue, pain, and anorexia-cachexia.
Cancer-related fatigue occurs in 30-90 % of cancer patients. 13 The pathophysiology of this symptom is poorly understood, but has been postulated to be related to the production of cytokines, serotonin neurotransmitter deregulation, hypothalamic pituitary axis disruption, circadian rhythm disturbance, vagal afferent activation, and alterations in muscle metabolism. 14 Moreover, secondary factors such as anemia, sleep disturbance, inactivity, poor nutrition, pain, electrolyte abnormalities, and neuroendocrine changes may also contribute to fatigue. Given its high prevalence, fatigue should be routinely screened. A detail assessment for associated symptoms, functional impairment, and possible causes is essential. Management of cancer-related fatigue consists of treatment of any reversible causes, such as pain and hypothyroidism. A recent Cochrane meta-analysis suggests that aerobic exercise is effective in reducing fatigue in both patients on treatment and afterwards. 15 However, the optimal duration has yet to be defined. Guidelines suggest moderate intensity exercises for 30 minutes per day most days of the week. 16 Psychostimulants such as methylphenidate and modafenil have mixed evidence for improving cancerrelated fatigue, and may be useful in selected patients. 17, 18 More recently, randomized controlled trials involving dexamethasone and American ginseng also demonstrated some potential benefit. 19, 20 Pain is another common symptom in patients with advanced cancer. It can affect patients' sleep, appetite, mood, function, and quality of life.
Assessment of cancer pain includes characterization of the nature, intensity, location, duration, and any previous treatments. For patients with mild pain, non-opioids such as acetaminophen may be appropriate. For patients with moderate to severe pain, opioids would be warranted. The following are some important principles when prescribing opioids:
1. All strong opioids have similar efficacy when administered at equianalgesic doses.
2. long-acting opioids given every 12 hours are equally efficacious as short-acting opioids given every 4 hours. 21 3. The rescue dose of opioids should be 10-20 % of the total daily dose given every 1-2 hours.
4. Patients should be educated in terms of the side effects of opioids.
Nausea and drowsiness may occur in opioid-naïve patients, and usually resolve within the first few days. This is in contrast to constipation, which persists throughout opioid treatment, and needs to be treated with laxatives preemptively. 22 5. Opioid rotation and use of adjuvant therapies may help to limit to the dose of opioids, minimize opioid-induced neurotoxicities (e.g. delirium, myoclonus, hallucinations, vivid dreams), and improve pain control. weeks. 28 Other agents being investigated for cancer anorexia-cachexia include anabolic agents (oxandrolone, testosterone, selective androgenreceptor modulators), appetite stimulants (ghrelin analogs), metabolic modulators (e.g. β-blockers), cytokine inhibitors (e.g. thalidomide,
anti-cytokine antibodies), nutrients (e.g. eicosapentaenoic acid), and antiinflammatory agents (nonsteroidal anti-inflammatory drugs [NSAIDs]).
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Psychologic Symptoms
Cancer patients experience significant psychologic distress throughout the trajectory of illness, starting from the time of diagnosis. A recent study demonstrated an increase in both suicide and death from cardiovascular events during the first week of cancer diagnosis. 31 Emotional distress may be a result of fears and worries related to the uncertainty of disease trajectory, changes in body image and sexuality, functional decline, loss of job, income, self-esteem and identity, altered family dynamics, decreased ability to participate in hobbies, as well as various spiritual and existential concerns. Indeed, approximately half of cancer patients have a psychiatric diagnosis, including adjustment disorders, major depression, anxiety, and delirium. 32, 33 These conditions may increase overall symptom expression and decrease quality of life. 34 Similar to physical symptoms, psychologic disorders should be screened routinely. For instance, the question "Are you depressed?" has been found to be useful for depression screening. 35 Nonpharmacologic management is vital to addressing psychologic concerns. Short-term psychotherapy, expressive supportive counseling, and cognitive behavioral therapy are useful for depressive and anxiety states in patients with advanced cancer. [36] [37] [38] Exercise has also been shown to improve depressive symptoms, particularly with supervised programs at least 30 minutes in duration. 39 For patients with severe depressive symptoms, selective serotonin reuptake inhibitors, tricyclic antidepressants, and psychostimulants may be helpful. 40 Patients should also be referred to a psychiatrist for further assessment. A recent Cochrane review found no studies meeting the inclusion criteria on pharmacologic intervention for anxiety in the palliative care setting. 41 Benzodiazepines are often used for anxiety. However, their use should be balanced against side effects such as drowsiness, fatigue, falls, delirium, and the potential for addiction. Neuroleptics and antidepressants may be reasonable alternatives for selected patients.
Spiritual distress is another important concern for patients, and may also exacerbate the expression of physical and emotional symptoms. 55, 56 and that a large proportion of them did not routinely discuss prognosis with their patients. 57 One explanation is the concern that disclosing a poor prognosis could destroy hope, despite recent evidence to the contrary. 58, 59 Another potential reason is the lack of formal communication training among oncologists. 8 Patients who reported to have had end-of-life discussions with their physicians were less likely to receive aggressive measures such as admission to an intensive care unit, mechanical ventilation, and resuscitation in the last week of life. 60 They were also more likely to receive care consistent with their preference, to be enrolled onto hospice, and to have a higher quality of life. 61 
Improved Symptom Control and Quality of Life
A meta-analysis consisting of 26 studies showed that palliative care was associated with improved pain and other nonpain symptoms. 70 Multiple randomized control trials comparing palliative care to routine oncologic care also demonstrated significant improvement in depressive symptoms and health-related quality of life in patients with advanced cancer.
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Improved Quality of Care
Palliative care involvement has a positive effect on multiple quality of end-of-life care outcomes. These include an increase in hospice referral and a reduction in intensive care unit admissions and deaths, emergency room visits, resuscitation, aggressive investigations, and chemotherapy use at the end of life. 72, 73 This is likely a result of proactive advance care planning and documentation of care goals. 60 
Improved Satisfaction with Care
Satisfaction is related to multiple aspects of care, such as patient-clinician communication, quality of life, and wait times. 74 Increased satisfaction may improve patient adherence. A meta-analysis reported a significant increase in patient satisfaction with palliative care involvement. 70 A more recent systematic review showed significant improvement in caregiver satisfaction and a trend towards improved patient satisfaction. 75 There is also emerging evidence that palliative care involvement can improve bereavement outcomes. 60 
Reduced Healthcare Costs
The end of life in cancer patients is marked by a sharp functional decline, acute complications, and increased symptom burden, often necessitating emergency room visits, hospitalizations, and intensive care unit stays. This increase in resource utilization is associated with a sharp rise in healthcare expenses in the last month of life, which constitutes 40 % of the total expense in the last year of life. 76 Through the avoidance of aggressive measures at the end of life, palliative care may not only improve quality of care but also reduce healthcare costs. This is supported by several randomized controlled trials and case series. [77] [78] [79] However, it should be noted that comprehensive palliative care service with an interprofessional team can also be resource intensive, and other studies have reported cost neutrality with palliative care involvement. 80 Taken together, palliative care
is financially sound and improves healthcare value. In addition to primary palliative care, many patients would benefit from secondary palliative care that involves referral to specialist palliative care teams. Palliative care programs were shown to be growing in a recent survey of US cancer centers, although there remains significant room for improvement in terms of infrastructure and the degree of integration. 7 Even when a comprehensive palliative care program is available, we found that less than half of the patients who died of advanced cancer received palliative care at our cancer center. 84 Moreover, patients were typically referred late in the disease trajectory (median 1.4 months from death), which significantly limits the effectiveness of palliative care programs. 4, 84, 85 Tertiary palliative care consists of academic palliative care specialists conducting research to advance our level of knowledge in supportive care. However, there are few palliative care research programs in US cancer centers. 7 Furthermore, palliative cancer care research is growing at a slower pace compared with the rest of the oncology field. 83 Increased research funding is needed to address this gap. 86 Figure 4 illustrates three models in care delivery: the solo practice model, congress model, and integrated care model. 87 The cancer care package
Models for Integration

